| Note | Year ended December 31, 2019 |
Year ended December 31, 2018 restated data* |
|
|---|---|---|---|
| STATEMENT OF PROFIT OR LOSS | |||
| SALES REVENUES | 7.1 | 37,627 | 25,946 |
| Cost of goods sold | 7.2 | (40,134) | (21,044) |
| GROSS PROFIT/ (LOSS) ON SALES | (2,507) | 4,902 | |
| Distribution and selling expenses | 7.2 | (1,361) | (1,406) |
| General and administrative expenses | 7.2 | (1,099) | (984) |
| Net other operating income/expenses | 7.3 | 792 | (30) |
| OPERATING PROFIT/(LOSS) | (4,175) | 2,482 | |
| Net finance costs, including: | 7.4 | (471) | (361) |
| Interest income calculated using the effective interest rate method | 36 | 45 | |
| Share of profit / (loss) of entities accounted for using the equity method | 7.5 | (57) | 71 |
| PROFIT/(LOSS) BEFORE TAX | (4,703) | 2,192 | |
| Income tax | 8.1 | 775 | (681) |
| NET PROFIT/(LOSS) FOR THE REPORTING PERIOD | (3,928) | 1,511 | |
| OTHER COMPREHENSIVE INCOME | |||
| Items that may be reclassified to profit or loss in the future: | |||
| Valuation of debt financial instruments | 20.3 | – | (6) |
| Valuation of hedging instruments | 20.3 | (336) | (158) |
| Foreign exchange differences from translation of foreign entities | 20.4 | – | 3 |
| Deferred tax | 8.1 | 65 | 31 |
| Items that may not be reclassified to profit or loss in the future: | |||
| Actuarial gains and losses from valuation of provisions for employee benefits | 22 | (266) | (207) |
| Deferred tax | 8.1 | 49 | 39 |
| Share of other comprehensive income of entities accounted for using the equity method | 7.5 | (5) | 1 |
| OTHER COMPREHENSIVE INCOME FOR THE REPORTING PERIOD, NET | (493) | (297) | |
| TOTAL COMPREHENSIVE INCOME | (4,421) | 1,214 | |
| NET PROFIT/(LOSS) ATTRIBUTABLE TO: | |||
| – equity holders of the parent company | (3,961) | 1,498 | |
| – non-controlling interests | 33 | 13 | |
| COMPREHENSIVE INCOME ATTRIBUTABLE TO: | |||
| – equity holders of the parent company | (4,453) | 1,202 | |
| – non-controlling interests | 32 | 12 | |
| EARNINGS AND DILUTED EARNINGS PER SHARE ATTRIBUTABLE TO EQUITY HOLDERS OF THE PARENT COMPANY (IN PLN) | 20.7 | (2.12) | 0.80 |
* Restatement of comparative data is described in note 5 to these consolidated financial statements.